p16INK4a has been widely accepted as a surrogate marker of E7 expression, and this protein is markedly expressed in many HPV-associated cancers; however, our results indicate that p16INK4a overexpression is not observed in all cases (Table 4). This evidence concerns the gene CDKN2A and cancer.